Compugen Stock

Compugen P/FCF

Delisted·Jun 15, 2026

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Compugen (CGEN) as of Jul 18, 2026 is 6.37. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 4.03 — a change of 57.96% (higher).

P/FCF

6.37

YoY

57.96%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Compugen is 2026 6.37 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Compugen was 2025 4.03 . It decreases by 57.96% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Compugen is 6.37 in 2026.

Access this data via the Eulerpool API

Valuation — Compugen

All Key Metrics — Compugen